- Home
- PHAR vs OLMA Comparison
PHAR vs OLMA Comparison
Compare PHAR & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- OLMA
- Stock Information
- Founded
- PHAR 1988
- OLMA 2006
- Country
- PHAR Netherlands
- OLMA United States
- Employees
- PHAR N/A
- OLMA N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- PHAR Health Care
- OLMA Health Care
- Exchange
- PHAR Nasdaq
- OLMA Nasdaq
- Market Cap
- PHAR 627.5M
- OLMA 525.7M
- IPO Year
- PHAR N/A
- OLMA 2020
- Fundamental
- Price
- PHAR $8.18
- OLMA $9.43
- Analyst Decision
- PHAR Strong Buy
- OLMA Strong Buy
- Analyst Count
- PHAR 2
- OLMA 5
- Target Price
- PHAR $33.50
- OLMA $27.00
- AVG Volume (30 Days)
- PHAR 6.6K
- OLMA 417.7K
- Earning Date
- PHAR 10-24-2024
- OLMA 11-12-2024
- Dividend Yield
- PHAR N/A
- OLMA N/A
- EPS Growth
- PHAR N/A
- OLMA N/A
- EPS
- PHAR N/A
- OLMA N/A
- Revenue
- PHAR $285,745,000.00
- OLMA N/A
- Revenue This Year
- PHAR $20.89
- OLMA N/A
- Revenue Next Year
- PHAR $11.15
- OLMA N/A
- P/E Ratio
- PHAR N/A
- OLMA N/A
- Revenue Growth
- PHAR 30.64
- OLMA N/A
- 52 Week Low
- PHAR $6.65
- OLMA $8.51
- 52 Week High
- PHAR $13.20
- OLMA $17.10
- Technical
- Relative Strength Index (RSI)
- PHAR 47.63
- OLMA 28.00
- Support Level
- PHAR $7.70
- OLMA $11.46
- Resistance Level
- PHAR $8.28
- OLMA $13.06
- Average True Range (ATR)
- PHAR 0.41
- OLMA 0.80
- MACD
- PHAR -0.07
- OLMA -0.23
- Stochastic Oscillator
- PHAR 44.27
- OLMA 0.00
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.